CD40LG and hepatocellular carcinoma: The IgM-bound AIM counts of patients with NASH-HCC did not significantly increase compared with those of healthy volunteers and patients with NASH; however, a weak, yet statistically significant, increase was observed compared with the NAFL group (p = 0.028; Fig. 4c).